# US 2015/0104432 A1 · Complete human skin organ generated from culture-expanded cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0104432 A1
- Document ID: US20150104432A1
- Status: Published application
- Kind: A1
- Application number: 14/514,364
- Filed: 2014-10-14
- Published: 2015-04-16
- Earliest claimed: 2013-10-11
- Assignees: MWV Cell, LLC
- Applicants: MWV Cell, LLC
- Inventors: Xunwei Wu; Bryan T. Marshall; Minh Vo
- Web page: https://patentgrep.com/patent/US20150104432A1

## CPC

- A61K 35/36: Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells (islets of Langerhans A61K35/39)
- A61L 27/60: Materials for use in artificial skin
- C12N 5/0698: {Skin equivalents}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Systems and methods can support generation of a full-thickness, human skin organ from tissue culture expanded cells. Human dermal and epidermal progenitor cells can be isolated from human tissues. Isolated cells may be cultured as epidermal cells while other isolated cells may be separately cultured as dermal cells. The cultured epidermal cells and dermal cells may be combined for co-culturing. The co-cultured cells may be suspended within a slurry. The co-cultured cells may be implanted onto a recipient organism for generation of a full-thickness skin organ comprising fully cycling hair follicles, adipose tissue, and other skin organ structures.

## Claims

### Claim 1

A method for skin organ generation comprising:
isolating cells from human tissues;
culturing isolated epidermal cells;
culturing isolated dermal cells;
combining cultured epidermal cells and cultured dermal cells;
co-culturing the combined epidermal cells and dermal cells;
implanting co-cultured cells onto a recipient organism; and
supporting generation of a full-thickness skin organ from the implanted cells, wherein the skin organ comprises fully cycling hair follicles.

### Claim 2 (depends on 1)

The method of claim 1, further comprising the step of applying the co-cultured cells to a substrate, and wherein implanting comprises attaching the substrate to the organism.

### Claim 3 (depends on 1)

The method of claim 1, wherein isolating cells from human tissues comprises isolating adult or fetal, hair follicle cells.

### Claim 4 (depends on 1)

The method of claim 1, wherein isolating cells from human tissues comprises isolating neonatal foreskin cells.

### Claim 5 (depends on 1)

The method of claim 1, wherein culturing isolated epidermal cells comprises exposing the cells to a rho kinase inhibitor.

### Claim 6 (depends on 1)

The method of claim 1, wherein co-culturing the combined epidermal cells and dermal cells occurs in the presence of less than ten percent oxygen.

### Claim 7 (depends on 1)

The method of claim 1, wherein isolating cells from human tissues comprises identifying highly trichogenic, SOX2 positive cell populations.

### Claim 8 (depends on 1)

The method of claim 1, wherein the generated skin organ supports wound healing.

### Claim 9 (depends on 1)

The method of claim 1, wherein the organism is a non-human laboratory animal and the generated skin organ supports a human skin model for testing or experimentation.

### Claim 10 (depends on 1)

The method of claim 1, wherein the skin organ comprises sweat glands, nerves, and subcutis.

### Claim 11

A method for skin organ generation comprising:
isolating cells from human tissue, wherein the cells comprise pluripotent follicle-derived cells;
culturing isolated epidermal cells, wherein culturing the isolated epidermal cells comprises exposing the cells to a rho kinase inhibitor;
culturing isolated dermal cells;
combining cultured epidermal cells and cultured dermal cells;
co-culturing the combined epidermal cells and dermal cells under conditions to enrich SOX2 expression;
implanting co-cultured cells onto a recipient organism; and
supporting generation of a full-thickness skin organ from the implanted cells, wherein the skin organ comprises fully cycling hair follicles.

### Claim 12 (depends on 11)

The method of claim 11, wherein isolating cells from human tissues comprises isolating neonatal foreskin cells.

### Claim 13 (depends on 11)

The method of claim 11, wherein isolating cells from human tissues comprises identifying highly trichogenic cell populations.

### Claim 14 (depends on 11)

The method of claim 11, wherein the skin organ comprises sweat glands, nerves, and subcutis.

### Claim 15 (depends on 11)

The method of claim 11, wherein the generated skin organ supports wound healing.

### Claim 16 (depends on 11)

The method of claim 11, wherein the generated skin organ supports hair regeneration.

### Claim 17 (depends on 11)

The method of claim 11, wherein co-culturing the combined epidermal cells and dermal cells occurs in the presence of less than ten percent oxygen.

### Claim 18 (depends on 11)

The method of claim 11, further comprising the steps of suspending the co-cultured cells into a slurry and applying the slurry to a substrate prior to implanting.

### Claim 19 (depends on 11)

The method of claim 11, wherein the organism is a non-human laboratory animal and the generated skin organ supports a human skin model for testing or experimentation.

### Claim 20

A method for skin therapy comprising:
isolating cells from human tissue, wherein the cells comprise pluripotent follicle-derived cells;
culturing isolated epidermal cells, wherein culturing the isolated epidermal cells comprises exposing the cells to a rho kinase inhibitor;
culturing isolated dermal cells;
combining cultured epidermal cells and cultured dermal cells;
co-culturing the combined epidermal cells and dermal cells;
suspending the co-cultured cells into a slurry;
applying the slurry to a substrate;
implanting co-cultured cells onto a wound by attaching the substrate to tissue adjacent to the wound;
dressing the implanted wound; and
supporting generation of a full-thickness skin organ from the implanted cells, wherein the skin organ comprises epidermis, dermis, and hypodermis layers and functions through fully-cycling hair follicles, sweat glands, and adipose tissue.
